Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

BACKGROUND: Access to medicines in developing countries continues to be a significant problem due to lack of insurance and lack of affordability. Chronic Myeloid Leukemia (CML), a rare disease, can be treated effectively, but the pharmaceutical treatment available (imatinib) is costly and unaffordab...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kanavos, Panos, Vandoros, Sotiris, Garcia-Gonzalez, Pat
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2009
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2806257/
https://ncbi.nlm.nih.gov/pubmed/20043820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1744-8603-5-19
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky